Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Donald G. Vidt, MD
Senior physician, Department of Nephrology and Hypertension, Cleveland Clinic; Professor of Internal Medicine, Ohio State University; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure